Patents by Inventor Gil Ma

Gil Ma has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ADAMANTYL DIAMIDE DERIVATIVES AND USES OF SAME
    Publication number: 20100022546
    Abstract: The present invention provides adamantyl-diamide derivatives of formula (1): wherein R1 and R2 are as defined herein, or a pharmaceutically acceptable salt thereof; and pharmaceutical compositions and methods using the same.
    Type: Application
    Filed: July 17, 2009
    Publication date: January 28, 2010
    Applicant: H. LUNDBECK A/S
    Inventors: Hermogenes N. Jimenenz, Guiying Li, Dario Doller, Michel Grenon, Andrew D. White, Gil Ma, Maojun Guo
  • BETA-LACTONE COMPOUNDS
    Publication number: 20090124681
    Abstract: The present invention provides compounds having the general structure A, or a pharmaceutically acceptable derivatives thereof: wherein R is an alkyl group, and R1 comprises at least one moiety selected from a group consisting of an alkyl, an alkenyl, an aryl, a heterocycle, hydroxyl, ester, amido, aldehyde, and a halogen.
    Type: Application
    Filed: October 30, 2008
    Publication date: May 14, 2009
    Applicants: Burnham Institute for Medical Research, The Texas A & M University System
    Inventors: Jeffrey W. Smith, Daniel Romo, Gil Ma, Manuel Zancanella
  • Novel method for the asymmetric synthesis of beta-lactone compounds
    Publication number: 20060258620
    Abstract: The present invention features methods of treating a cancer in a subject by administering an effective amount of a beta-lactone to the subject. The invention also features methods of inhibiting angiogenesis in a subject by administering an effective amount of an inhibitor of fatty acid synthase to the subject. These methods can be used to treat a variety of cancers and other diseases and conditions. The invention also features methods of identifying beta-lactones and other compounds that can be used in the methods of the invention for the treatment of tumors, inhibition of angiogenesis, and the treatment of diseases and conditions that involve pathological angiogenesis. The invention also features methods of synthesizing beta-lactones and features novel beta-lactone compounds.
    Type: Application
    Filed: March 16, 2006
    Publication date: November 16, 2006
    Applicant: Burnham Institute for Medical Research
    Inventors: Jeffrey Smith, Fumiko Axelrod, Steven Kridel, Daniel Romo, Vikram Purohit, Gil Ma